1. Bacterial and Curable STDs Gonorrhea, Chlamydia, Syphilis and Trichomoniasis Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Attending Physician Ronald Reagan Medical Center Program in Global Health and Division of Infectious Diseases David Geffen School of Medicine Department of Epidemiology Karin and Jonathan Fielding School of Public Health AAHIVU August 2014

2. Disclosures Dr. Klausner is a faculty member of the University of California Los Angeles Dr. Klausner is a guest researcher with the US CDC Mycotics Diseases Branch Dr. Klausner is a member of the WHO STD Guidelines group Dr. Klausner is a board member of YTH, Inc, non-profit Dr. Klausner is medical advisor for Healthvana.com In the past 12 months, Dr. Klausner has received: –Travel support for meeting coordination and speaking from Standard Diagnostics, Inc. –Research funding or donated supplies from the NIH, CDC, Hologic, Inc., Alere, Inc., Chembio, Inc. Cepheid, Standard Diagnostics, Inc., and MedMira, Inc. JDKlausner@mednet.ucla.edu

3. Today’s talk Gonorrhea Chlamydia Syphilis Trichomoniasis

4. Case 28 year old man with urethral discharge 4

5. Name of piercing ? a) Prince Charles b) Prince Harry c) Prince William d) Prince Albert

6. Prince Albert ring The Prince Albert is one of the more common male genital piercings The Prince Albert is a ring-style piercing that extends along the underside of the glans from the urethral opening to where the glans meets the shaft of the penis Legend has it that Prince Albert used the ring to fix his penis to his thigh while wearing pants in court Ferguson, H. Body Piercing. BMJ 1999 6

7. Differential diagnosis of urethritis Infectious Neisseria gonorrhoeae Chlamydia trachomatis Mycoplasma genitalium Trichomonas vaginalis Herpes simplex virus 1 and 2 Oral flora---streptococci, anaerobes, haemophilus sp., adenoviruses Non-infectious Trauma--physical or chemical (drugs), post-catheterization or sex-play related Autoimmune--Reiter’s syndrome

8. Uncomplicated gonococcal infection Neisseria gonorrhoeae Urethra Cervix Pharynx Rectum Gram stain of urethral discharge 1000x Gram-negative intracellular diplococci

9. Detection of gonococcal infection Nucleic acid amplification tests (NAATs) –PCR, SDA, TMA sensitivity 95% specificity >99.7% -- NAATs FDA-cleared in urethra, cervix, urine, vagina, self-obtained vaginal specimens –Verified in pharynx and rectum  Gram stain sensitivity92% specificity90%  Culture sensitivity95% specificity99%

10. Gonorrhea—Rates, United States, 1941–2012 2012-Fig 11. SR, Pg 19

11. Gonorrhea—Rates by County, United States, 2012 2012-Fig 20. SR, Pg 21

12. Gonorrhea—Rates by Age and Sex, United States, 2012 2012-Fig 21. SR, Pg 21

13. Gonorrhea—Rates by Race/Ethnicity, United States, 2008–2012 † NHOPI = Native Hawaiian and Other Pacific Islanders. NOTE: Includes 38 states and the District of Columbia reporting race/ethnicity data in Office of Management and Budget compliant formats during 2008–2012. 2012-Fig 19. SR, Pg 23

14. 14 Percentage of Isolates in Which Minimal Inhibitory Concentrations (MICs) of Cefixime Were 0.25 μg/mL or Higher, 2005–2011 Bolan GA et al. N Engl J Med; Feb., 2012

15. What is the current recommended treatment for gonorrhea? A) Ceftriaxone 250 mg IM once B) Ceftriaxone 250 mg IM once + azithromycin 1 gm PO once C) Ceftriaxone 250 mg IM once + doxycycline 100 mg PO once D) Cefixime 400 mg PO once E) Ciprofloxacin 500 mg PO once + azithromycin 1 gm PO once Plus partner treatment 15 MMWR CDC STD Treatment Guidelines Update, August 2012

16. Multi-drug treatment for gonorrhea Ceftriaxone 250 mg IM once AND azithromycin 1 gm PO once or doxycycline 100 mg PO twice daily x 7 days Plus partner treatment Retesting at 3 months 16 MMWR CDC STD Treatment Guidelines Update, August 2012

17. Penicillin, Tetracycline, and Ciprofloxacin Resistance Among Neisseria gonorrhoeae Isolates, 2012 NOTE: PenR = penicillinase producing Neisseria gonorrhoeae and chromosomally mediated penicillin- resistant N. gonorrhoeae; TetR = chromosomally and plasmid mediated tetracycline-resistant N. gonorrhoeae; and QRNG = quinolone-resistant N. gonorrhoeae. 2012-Fig 27. SR, Pg 27

18. Fluoroquinolone resistance in Neisseria gonorrhoeae 18

19. Real-time PCR Melting Curves: FRET probe binding to gyrA at serine 91 detects the susceptibility of the specimen 19 Siedner et al, JCM, 2007; Siedner et al, Int J STD AIDS, 2008

20. Molecular-based resistance testing Rapid detection of NG Simultaneous detection of key antimicrobial resistance profile Enable targeted treatment Reduce antibiotic selection pressure Decrease emergence of resistance 20 UNDER DEVELOPMENT-R21AI109005

21. Case 19 year old female used SexInfo text message service (Text “SexInfo” to 61827) and comes in for a check-up. She has one regular partner for 6 months and has no symptoms. What STD screening tests are appropriate?

22. Recommended STI screening in sexually active female < 25 years Chlamydia trachomatis and Neisseria gonorrhoeae, annually HIV test Consider Trichomonas vaginalis (increased risk) Herpes simplex virus type 2 antibody Avoid PAP smear (only if sexually active > 3 years) Syphilis USPSTF, 2013; AAP July 2014

23. Screening tests for chlamydial infection Nucleic acid amplification tests –DNA amplification (Roche, Bayer, Abbott, BD, Seimens, Cepheid) –RNA amplification (Hologic)

24. Options for specimen collection 1) Cervical swab 2) Vaginal swab 3) Self-collected vaginal swab 4) Urine 5) Rectal swab 6) Self-collected rectal swab

25. Rectal Chlamydia Positivity, San Francisco (n=6,861) 25 Mean positivity 8.4% (n=576+)

26. Most rectal chlamydial infections in gay/bisexual men are asymptomatic, San Francisco 26 Rectal chlamydia n=316 14% 86% Kent et al. Clin Inf Dis, 2005

27. Cervicitis STD Atlas, Mosby: 1997 Mucopurulent dischargeFriability Slide courtesy of M. Leibowitz

28. Swab Test in Cervicitis Positive Swab Test Negative Swab Test STD Atlas, Mosby: 1997 Slide courtesy of M. Leibowitz

29. What is best treatment for uncomplicated chlamydial infection? 1)Azithromycin 1 gm orally once 2)Doxycycline 100 mg orally twice daily for 7 days 3)Amoxicillin 500 mg po tid x 7 days 4)Levofloxacin 500 mg po qd x 7 days 5)None of the above

30. Treatment for uncomplicated chlamydial infection 1)Azithromycin 1 gm orally once 2)Doxycycline 100 mg orally twice daily for 7 days 3)Amoxicillin 500 mg po tid x 7 days 4)Levofloxacin 500 mg po qd x 7 days Partner treatment –SB 648, CA Law January 2001 Re-testing at 3 months

31. Chlamydia—Rates by Sex, United States, 1992–2012 NOTE: As of January 2000, all 50 states and the District of Columbia have regulations that require the reporting of chlamydia cases. 2012-Fig 1. SR, Pg 9

32. Reported cases of Chlamydia trachomatis San Francisco women, 1993–2004 Moss N J et al. J Infect Dis. 2006;193:1336-1338 Reported pelvic inflammatory disease cases San Francisco County, 1993–2004 Ectopic pregnancies San Francisco General Hospital 1993–2004 Chlamydia screening and treatment reduces sequelae

33. Chlamydia—Prevalence Among Persons Aged 14–39 Years by Sex, Race/Ethnicity, or Age Group, National Health and Nutrition Examination Survey, 2005–2008 NOTE: Error bars indicate 95% confidence intervals. 2012-Fig 10. SR, Pg 13

34. 34 44 year old man with new lesion near his anus Case

35. Differential diagnosis of anogenital ulcer Sexually transmitted diseases Primary syphilis Genital herpes Chancroid Other Fixed drug reactions –NSAIDs, tetracyclines, foscarnet Skin flora infections Autoimmune conditions

36. 36 1000x darkfield microscopy Treponema pallidum pallidum, bacterial spirochete

37. All those syphilis tests Non-treponemal tests (RPR, VDRL) –Antibody to cardiolipin-lecithin-phospholipids –Rise and fall with infection and treatment over time –4-fold change in titer (1:2 to 1:8 or 1:64 to 1:16) is significant –Specificity = 98% (false-positives in IDU, auto-immune, etc) Treponemal tests (FTA-Abs, TPPA, TP EIA) –Antibody to Treponemal antigen –More sensitive and develop earlier –Stay positive for “life” (85%) –Indicate past or current infection 37 Klausner, Current STD Diagnosis and Management 2007

38. Primary syphilis – penile chancres

39. Secondary syphilis: trunk rash

40. Secondary syphilis: palmar and plantar lesions

41. www.merckmedicus.com Secondary syphilis: split papules, “moth-eaten” alopecia, mucous patches, and condyloma lata Split papule (mucous patch) Mucous patch Moth-eaten alopecia J. Engelman Mucous patch Condyloma lata Katz

42. Latent syphilis This page intentionally left blank!

43. Syphilis—Reported Cases by Stage of Infection, United States, 1941–2012 2012-Fig 29. SR, Pg 32

44. Primary and Secondary Syphilis—Rates by Age and Sex, United States, 2012 2012-Fig 35. SR, Pg 35

45. Primary and Secondary Syphilis—Rates by Race/Ethnicity, United States, 2008–2012 * AI/AN = American Indians/Alaska Natives; NHOPI = Native Hawaiian and Other Pacific Islanders. NOTE: Includes 38 states and the District of Columbia reporting race/ethnicity data in Office of Management and Budget compliant formats during 2008-2012. 2012-Fig 38. SR, Pg 36

46. What is the recommended treatment for early syphilis? A) Azithromycin 1 gm PO once B) Azithromycin 1 gm weekly for 3 weeks C) Amoxicillin 500 mg PO tid x 7 days D) Penicillin G benzathine 2.4 MU IM once E) Penicillin G aqueous 600,000 U IV q 4-6 x 10 days Plus partner treatment 46 CDC STD Treatment Guidelines, 2010

47. Primary & Secondary and Latent < 1 year syphilis treatment HIV (-)/(+)2.4 million units of benzathine penicillin G-LA Pregnant2.4 million units of benzathine penicillin G-LA PCN-allergic: HIV(-)/(+)doxycycline 100 mg po bid x 14 d Pregnantdesensitize, then benzathine penicillin G-LA CDC STD Treatment Guidelines, 2010 Prophylactic treatment: All contacts to syphilis within past 90 days should be treated regardless of serologic test result with benzathine penicillin G 2.4 MU IM once

48. Syphilis and HIV infection Multiple chancres May present with overlapping primary and secondary manifestations Rarely abnormal serology but slower decline Increased risk neurosyphilis Zetola and Klausner, Clin Inf Dis 2007.

49. AIDS, 2004

50. San Francisco, early 2000s San Francisco, 2009 Texas

51. Case 32 y female seen w/ new vaginal discharge Reports no new sex partners, monogamous for > 5 years

52. Differential diagnosis of vaginal discharge Infectious Vaginitis Trichomonas vaginalis Bacterial vaginosis Candida albicans and other Cervicitis Neisseria gonorrhoeae Chlamydia trachomatis Herpes simplex virus 1 and 2 Non-infectious Mechanical, chemical or allergic irritation

53. Trichomoniasis Trichomonas vaginalis Vagina Cervix Urethra

54. Detection of T. vaginalis infection SensitivitySpecificity Wet mount40-80%90% Culture95%99% IA90-95% 93-100% PCR/ TMA95%99%

55. Treatment of trichomoniasis MetronidazoleCure rate 2 gm po x 1 95% 500 mg po bid x 5-7 95% Partner management—Treat partners Hager D et al., JAMA, 1980; Thin et al., Br J Ven Dis, 1979.

56. Prevalence of Trichomonas vaginalis among non-Hispanic black women, compared with the prevalence among women from all other racial/ethnic groups, by age, 2001–2004 Sutton M et al. Clin Infect Dis. 2007;45:1319-1326 ©2007 by Oxford University Press

57. Sources for more STD information Me –JDKlausner@mednet.ucla.eduJDKlausner@mednet.ucla.edu CDC –www.cdc.gov/stdwww.cdc.gov/std Current STD Management Textbook

58. Thank you